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Previous  studies  from  several  aboratories  have 
shown that  thrombin is inactivated by tetranitrometh- 
ane  with  the formation of nitrotyrosine.  The  inactiva- 
tion is characterized by an  apparently  greater loss of 
fibrinogen-clotting  activity than  activity  toward  syn- 
thetic ester substrates, suggesting that the residues 
modified by tetranitromethane  are involved in  the  in- 
teraction of thrombin  with  fibrinogen.  This  study  was 
designed 1) to  determine  the effect of solvent condi- 
tions on the rate of modification and  the stoichiometry 
of the  reaction of tetranitromethane  with bovine a- 
thrombin; 2) to  identify  the residue(s) modified; and 3) 
to characterize  the modified enzyme with respect to its 
interaction with peptide nitroanilide substrates and 
fibrinogen. 
The  inactivation of thrombin by tetranitromethane 
proceeded more  rapidly  in 50 mM Tris, pH 8.0, than  in 
50 mM sodium phosphate, 100 mM NaCl, pH 8.0. Ap- 
proximately 10% fibrinogen-clotting  activity  re- 
mained at maximal  inactivation. A study of the effect 
of tetranitromethane  concentration on the  rate of in- 
activation  suggested  that  the loss of activity  was  the 
result of the modification of 1 mol  of tyrosine/mol of 
thrombin. A similar result was obtained from the 
analysis of the  extent of inactivation as a  function of 
the  extent of protein modification. Structural  analysis 
of the modified protein showed substantial modifica- 
tion at both  Tyr7’  and  Tyr”. Enzyme kinetic  studies 
were performed with  the modified protein  and a con- 
trol  thrombin  with W-tosylglycylprolylarginine p-ni- 
troanilide, H-D-phenylalanylpipecolylarginine p-ni- 
tronailide, and purified bovine fibrinogen. With all 
three substrates, a substantial decrease in kc,, was 
observed, whereas  there  was essentially no change  in 
K,. These  results  suggest  that,  contrary  to previous 
suggestions, the modification of Tyr71 and Tyrss in 
thrombin does not influence the  binding of substrates, 
but  rather influences  active site  reactivity. 
Thrombin  is a trypsin-like regulatory serine  protease  with 
diverse biological activities (1) primarily recognized as the 
enzyme  responsible for conversion of fibrinogen to fibrin in 
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the process of blood coagulation. The elucidation of the  struc- 
tural  factors  in  thrombin responsible for the specific interac- 
tion with  fibrinogen has  been  the subject of study  in a number 
of laboratories.  Some approaches have  used  limited  proteoly- 
sis of a-thrombin  to  obtain derivative forms  such  as  8-throm- 
bin (2, 3) and  y-thrombin (4-6). Although there  has been  a 
significant amount of work on these proteins, information 
regarding specific regions of thrombin  critical for interaction 
with fibrinogen is still lacking. Other studies (7, 8)  have 
attempted to use specific chemical modification to explore 
structural features of thrombin outside of the active site 
region. 
The  reaction of thrombin with tetranitromethane  (TNM)’ 
is  an example of such a  modification. The  partial  inactivation 
of thrombin by TNM was first  reported by Astrup  in 1947 
(9). Subsequent  studies by Sokolovsky and  Riordan (10) 
showed that fibrinogen-clotting activity was lost more  rapidly 
than esterase activity. Our laboratory (11) extended these 
earlier  studies  and  demonstrated  that  the  reaction of throm- 
bin with TNM resulted in the formation of nitrotyrosine 
residues. None of these  studies  established stoichiometry for 
the  reaction,  nor were there  efforts  to identify the  site(s) of 
modification. However, the above studies  on  the reaction of 
TNM with thrombin  are  consistent with the  hypothesis  that 
tyrosyl  residues are involved in  the processing of fibrinogen 
as a substrate  but may not be involved with thrombin catalysis 
of smaller, synthetic  substrates.  These  studies were designed 
both to test this hypothesis as well as to characterize the 
modified protein as obtained  under well-defined reaction  con- 
ditions. 
MATERIALS AND METHODS 
Bovine a-thrombin was prepared as described by Workman and 
Lundblad (12). Bovine fibrinogen (60% clottable) was obtained from 
Miles. For the assay of thrombin using fibrinopeptide release, the 
fibrinogen was purified by ammonium sulfate fractionation as de- 
scribed by Hageman and Scheraga (13). p-Chlorobenzylamido-ami- 
nocaproyl-agarose was prepared as described by Thompson (14). 4- 
Chlorobenzylamine and  tetranitromethane were obtained from Ald- 
rich. Tosylglycylprolylarginine p-nitroanilide (Tos-Gly-Pro-Arg- 
pNA) was obtained from Sigma, whereas H-D-phenylalanylpipecoly- 
largininep-nitroanilide (H-D-Phe-Pip-Arg-pNA) was a product of  AB 
Kabi and was obtained from Helena Laboratories. p-Nitropheny1-p’- 
guanidinobenzoate (NPGB) was obtained from Research Organics. 
The C,, reverse-phase column (Cis type TP silica, 4.6 mm, inner 
diameter, X 25 cm) was obtained from The Separations Group. All 
‘ The abbreviations used are: TNM, tetranitromethane; NPGB, p- 
nitrophenyl-p’-guanidinobenzoate; HPLC, high-performance liquid 
chromatography; Tos-Gly-Pro-Arg-pNA; Ne-tosylglycylprolylargi- 
nine p-nitroanilide; H-D-Phe-Pip-Arg-pNA, H-D-phenylalanylpipe- 
colylarginine p-nitroanilide; HEPES, 4-(2-hydroxyethyl)-l-pipera- 
zineethanesulfonic acid. 
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other chemicals were  of reagent-grade and used without further 
purification. 
a-Thrombin was dialyzed into either 50 mM Tris, pH 8.0, or 50 
mM sodium phosphate, 100 mM NaC1, pH 8.0, for 4 h at ambient 
temperature prior to modification with TNM. There was no change 
in the specific activity of the  a-thrombin preparation as a result of 
the dialysis procedure. The preparations of a-thrombin used in  these 
experiments were typical of previous preparations of a-thrombin (12) 
with a specific activity of  2000-2500 NIH  units/mg of protein without 
correction for active site concentration. The reaction of TNM was 
performed essentially as described by Riordan and Vallee (15) except 
that  the reactions were terminated by the addition of a 1.3 M excess 
of cysteine to  TNM,  and, unless otherwise indicated, the modified 
proteins were dialyzed into 50 mM Tris,  pH 8.0, prior to further study. 
Spectra (230-600 nm) were obtained for all modified proteins  both to 
establish nitrotyrosine formation and  to evaluate possible modifica- 
tions of tryptophan residues. The extent of nitrotyrosine formation 
was determined by spectroscopy of the modified protein in 0.1 M 
NaOH using the extinction coefficient at 428 nm reported in the 
literature (15). Protein  concentration of native thrombin was deter- 
mined by spectroscopy at 280 nm using a milligram/milliliter extinc- 
tion coefficient of 1.7 (16). The protein concentration of modified 
proteins was determined by the biuret reaction (17,  18). Samples for 
structural analysis were reduced and carboxymethylated basically as 
described by Canfield and Anfinsen (19). Tryptic hydrolysis was 
performed on 250-500-pg samples in 100 mM sodium bicarbonate, pH 
8.0, with L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated 
trypsin which had been previously allowed to  stand  in 1 mM HC1 
(20). The tryptic hydrolysates were taken directly to a Cla reverse- 
phase column. The columns were developed as described in  the  text, 
and effluent was monitored at 210,280, and 360  nm. Selected effluent 
peaks were subjected to amino-terminal sequence analysis using a 
Beckman 890 automated sequenator (21). 
Fibrinogen-clotting activity was determined as previously de- 
scribed (22). All thrombin preparations were evaluated for active site 
integrity using NPGB (231, and kinetic data were corrected for 
percent active sites. All preparations had at least 80% active sites. 
Affinity chromatography of native and modified thrombin prepara- 
tions  on p-chlorobenzylamido-aminohexyl-agarose was performed at  
ambient  temperature. The sample, containing 500-1000  pg  of protein 
in 50 mM Tris-HC1, pH 8.0, was applied to a 0.9 X 15-cm column 
previously equilibrated with 30 mM sodium phosphate, 0.75 M NaCl, 
pH 8.0. After emergence of unabsorbed material, thrombin was eluted 
with 25% 1,4-dioxane in 30 mM sodium phosphate, 0.75 M NaCI, pH 
8.0, essentially as described by Thompson (14). Native and modified 
thrombin  preparations were subjected to high-performance size-ex- 
clusion chromatography as described by Tarvers (24) using a TSK- 
3000SW column in 50 mM HEPES, 150 mM NaCl, pH 6.8.  An  JSCO 
high-performance liquid chromatography system was used in  these 
studies. Amidase activity with the peptide nitroanilide substrates was 
determined in 50 mM Tris, pH 8.0, and  the release of nitroaniline 
was followed at 405 nm (25) using a Kontron 810/820 UV-VIS 
spectrophotometer. The absorbance data were converted directly to 
rate data using linear regression analysis using the data analysis 
module of the spectrophotometer. Kinetic constants were determined 
using nonlinear regression analysis (26,  27). The hydrolysis of fibrin- 
ogen by thrombin resulting in the release of fibrinopeptide A was 
performed in 0.15 M ammonium acetate, pH 8.0 (28), in the presence 
of 100 mM 6-aminohexanoic acid (29). Portions of the reaction 
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FIG. 1. Inactivation of thrombin by tetranitromethane in sodium phosphate buffer. A, semilogarithmic 
plot of the  rate of loss of fibrinogen-clotting activity as a function of time at different concentrations of TNM. 
The concentration of thrombin was  30 pM, and  the  TNM concentrations were  1.66 (O), 3.31 (O), 4.98 (A), 6.64 
(A), 8.30 ( 0 ,  and 12.45 (W) mM in 50 mM sodium phosphate, 100 mM NaCl, pH 8.0. Reactions were initiated by 
the addition of TNM (diluted in absolute EtOH), and portions were  removed at  the indicated times, diluted in 
cold  60 mM Tris-HC1, 90 mM NaCI, pH 7.5, and assayed for residual fibrinogen-clotting activity. The amount of 
residual activity remaining after 30 min of reaction at the highest concentration of TNM waa 10% of initial activity 
and was taken equal to F for the calculations. B, plot of the log first-order rate constants (k’) as determined from 
the data in A versus log TNM concentration. The slope of the line obtained in B determined by linear regression 
analysis was  1.10 with r = 0.98. 
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FIG. 2. Inactivation of  thrombin  by  tetranitromethane in Tris-Clo buffer. A, semilogarithmic  plot of 
the rate of loss of fibrinogen-clotting activity as function of time at different concentrations of TNM. The 
concentration of thrombin was 30 GM, and the TNM concentrations were 1.66 (a), 3.31 (0), 4.98 (m), 6.64 (O), 
8.30 (A), and 12.45 (A) mM in 50 mM sodium  phosphate, 100 mM NaCl,  pH 8.0. Reactions were initiated by the 
addition of TNM  (diluted in absolute  EtOH), and portions were removed at the indicated times,  diluted in cold 60 
mM Tris-HC1, 90 mM NaC1,  pH 7.5, and  assayed for residual  fibrinogen-clotting  activity.  The  amount of residual 
activity  remaining after 30 min of reaction at the  highest  concentration of TNM was 10% of initial  activity and 
was taken equal to F for the calculations. B,  plot of the log first-order rate constants (k’) as determined from the 
data in A versus log  TNM  concentration.  The slope of the line obtained in B determined by linear  regression 
analysis was 1.13 with r = 0.96. 
acid to terminate the reaction.  After  centrifugation, a portion of the 
supernatant fraction was analyzed by high-performance  liquid chro- 
matography  using a C,, reverse-phase  column with an isocratic  eluent 
of 0.05 M sodium phosphate, pH 3.1, acetonitrile (81:19). The  kinetic 
constants for  fibrinopeptide A release were determined by nonlinear 
regression analysis as cited above. 
RESULTS 
Previous studies (10, 11) on the reaction of thrombin with 
TNM have shown that  there is residual fibrinogen-clotting 
activity remaining after  apparently complete reaction. Similar 
results were obtained in this study (data  not shown) where, 
under our assay conditions, 90% inactivation of thrombin 
fibrinogen-clotting activity was obtained upon maximum re- 
action with TNM. As a result, the residual activity must be 
considered in calculation of rate  constants for the inactivation 
reaction and for studying the stoichiometry of the inactivation 
reaction (30-32). The following equation was used in the 
calculation of the data described below: A/Ao = (1 - 
(32). 
Initial  experiments were performed in 50 mM sodium phos- 
phates, 100 mM NaC1, pH 8.0, as  in previous studies from this 
laboratory (11). First-order  rate  plots for the inactivation of 
thrombin  in this solvent over a range of TNM concentration 
are shown in Fig. lA. A double logarithmic plot of TNM 
concentration versus the observed first-order rate  constant is 
shown in Fig. 1B. The slope of the line obtained is 1.10, 
suggesting that inactivation is the result of reaction at a single 
site on the protein. Since we had observed that sodium ions 
influence the activity of purified bovine thrombin (33), the 
reaction of thrombin with TNM was also performed in 50 mM 
Tris-HC1, pH 8.0. A first-order rate plot of the inactivation 
of thrombin by TNM in this solvent is shown in Fig. 2 4 .  
Comparison of these data with those shown in Fig. lA reveals 
that  the inactivation reaction proceeds approximately 3 times 
more rapidly in Tris  than in the sodium-containing solvent. 
A double logarithmic plot of TNM concentration versus the 
observed first-order rate  constant for the reaction in Tris is 
shown in Fig. 2B. The slope of this line is 1.13, suggesting 
that,  as with the sodium phosphate solvent, the inactivation 
of thrombin by TNM in Tris is the result of reaction at single 
site on the protein. The decreased rate of inactivation ob- 
served in the phosphate buffer is not solely the result of 
increased ionic strength since the inclusion of 100 mM NaCl 
in  the  Tris buffer had  little effect on the  rate of reaction of 
TNM with thrombin. 
The above results suggest that  the inactivation of thrombin 
by TNM is the result of reaction at a single site in the protein. 
Previous studies (11) had shown that  the reaction of TNM 
with thrombin resulted in the modification of only tyrosine. 
Similar results were observed in  this study. In an  attempt  to 
establish stoichiometry for the inactivation reaction, the mod- 
ification of thrombin by TNM was performed under a variety 
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of solvent conditions, and the extent of modification was 
determined by spectral analysis. A plot of the extent of 
inactivation (after correction for residual activity) versus ni- 
trotyrosine formation is shown in Fig. 3. The results are 
consistent with the inactivation of thrombin by TNM result- 
ing from modification of a single tyrosine residue. 
The modified protein was then subjected to structural 
analysis. Fig. 4 represents the HPLC analysis of a tryptic 
digest of the modified protein  after reduction and carboxy- 
methylation. The effluent was monitored at 210,280, and 360 
nm.  Only the 360 nm profile showing the presence of nitro- 
tyrosine (15) is shown. The peaks absorbing at 360 nm were 
collected and subjected to amino-terminal sequence analysis. 
Two major sites of modification were observed, T y P  and 
Tyrs5, in the B chain with minor modification at Tyr2I5. A 
similar analysis of the human  protein showed modification at 
Tyr71 and Tyr- and lesser modification at TyP4.  There was 
also apparent modification at Trp14’ in the human protein. 
The modification reactions for these  proteins were performed 
in the sodium phosphate buffer. In an  attempt  to identify a 
single residue, the modification reaction was performed in 
both Tris buffer and  phosphate buffer, and  the two  modified 
proteins were subjected to  structural analysis. The results of 
this  experiment  are shown in Fig.  5. There was  no significant 
difference in  the extent of modification at Tyr71 and T y P .  
Since these  results suggested possible heterogeneity of the 
products derived from the modification of a-thrombin by 
TNM, we sought to demonstrate that there were multiple 
products resulting from the reaction of thrombin with TNM. 
We subjected the product of the modification reaction to 
chromatographic fractionation  on  SP-Sephadex C-50 under 
conditions demonstrated by our laboratory to separate mul- 
tiple forms of thrombin (2 ,3) .  The modified protein  chromat- 
ographed in an manner  identical to native a-thrombin.  Fur- 
thermore, the modified protein bound to p-chlorobenzylam- 
ido-eaminocaproylagarose (14) as effectively as the native 
7-
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FIG. 3. Relationship between loss of fibrinogen-clotting ac- 
tivity on thrombin and extent of formation of nitrotyrosine. 
Thrombin (290 nmol in 10 ml to reaction mixture (50 mM Tris-C1, 
pH 8.0)) was incubated with a 25-fold molar excess of TNM (O), a 
50-fold molar excess of TNM (O), a 50-fold molar excess of TNM in 
the presence of  200 mM NaCl (A), a 50-fold molar excess of TNM in 
the presence of 10 mM benzamidine (A), a 50-fold molar excess of 
TNM in the presence of  200 mM NaCl and 10 mM benzamidine (V), 
a 100-fold molar excess of TNM (O), a 100-fold molar excess of TNM 
in the presence of 10 mM benzamidine (m), or  a 100-fold molar excess 
of TNM in the presence of 200 mM NaCl (V). The reactions were 
initiated by the addition of TNM (diluted in absolute EtOH),  and 
portions were  removed at various times and added to a 1.3 M excess 
of cysteine (to TNM)  to terminate the reaction. After dialysis against 
0.1 M NH4C03, the samples were assayed for fibrinogen-clotting 
activity and content of nitrotyrosine (after  adjustment of pH to 12.0). 
The V, value is corrected for a residual activity (F) of 10% of a 
control preparation. 
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FIG. 4. Comparison of tryptic maps of TNM-modified 
thrombin. Thrombin was allowed to react with a 50-fold (trace A )  
or 200-fold (trace B )  molar excess of TNM for 30 min in 50 mM 
sodium phosphate, 100 mM NaCl, pH 8.0. The reactions were termi- 
nated by dialysis against 100 mM ammonium bicarbonate. The con- 
tent of nitrotyrosine was determined by spectroscopy after  adjustment 
of the pH to 12.0. The preparations were hydrolyzed with trypsin, 
and  the hydrolysates were chromatographed on a C,, column with an 
acetonitrile gradient. Effluent absorbance was monitored at 210,280, 
and 360 nm. The absorbance at 360 is shown. Discrete peaks absorb- 
ing at 360 nm were collected and subjected to primary structure 
analysis. Sequence information was compared with existing primary 
structure information to determine placement in the amino acid 
sequence of thrombin. 
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FIG. 5. Effect of solvent composition on sites of modification 
of thrombin with tetranitromethane. Preparations of thrombin 
were  modified with a 100-fold molar excess of TNM either  in 50 mM 
Tris-C1, pH 8.0 (trace A ) ,  or in 50 mM sodium phosphate, 100 mM 
NaCl, pH 8.0 (trace B ) .  The analyses were performed as described for 
Fig. 4. Absorbance was monitored at  210,  280, and 360  nm.  Only the 
absorbance at  360  nm is shown. The profiles shown were normalized 
to permit direct comparison as a function of protein concentration in 
hydrolysates (determined from total absorbance at 210 and 280 nm. 
MAU, milli-absorbance unit. 
protein and was eluted by the same solvent conditions. As 
with our previous study (ll), the modification of a-thrombin 
under these reaction conditions did not result in  the formation 
of dimer or higher aggregate forms of thrombin  as assessed 
by high-performance size-exclusion chromatography. 
The final portion of this work concerns the study of the 
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TABLE I
Effect of nitration of thrombin  on  hydrolysis of two  peptide 
nitroanilide substrates 
The assays were performed over a 50-fold range of substrate 
concentration in 50 mM Tris, 50 InM HEPES, 0.01% polyethylene 
glycol,  pH 7.8. Kinetic constants were obtained by nonlinear  regres- 
sion analysis of initial rate data as described in the text. 
Substrate K ,  kcat 
P M  S” 
Control 12.6 63.4 
Nitrated 16.7 44.8 
Control 20.9 90.4 




Effect of nitration of thrombin  on kinetic constants for release of 
fibrinopeptide A from fibrinogen 
The release of fibrinopeptide A from reaction mixtures  containing 
varying concentrations of fibrinogen in 0.15 M ammonium acetate, 
0.1 M 6-aminohexanoic acid, pH 8.0, was determined by high-perform- 
ance liquid  chromatography as described in the text. 
Enzyme source K ,  kat 
P M  S-1 
Control 9.6 299.0 
Nitrated 9.6 86.0 
enzymatic  properties of the modified protein. The activity of 
nitrated  thrombin  in  the hydrolysis of Tos-Gly-Pro-Arg-pNA 
and H-D-Phe-Pip-Arg-pNA was compared with that of a 
control thrombin preparation. Table I shows the results of 
this  study.  With  either  substrate,  there is only a minor  change 
in K,,,, whereas  there  is a ‘decrease  in k,,,. The calculations 
were made  after  correction for active  site  concentration in the 
two  enzyme preparations. The  data  are  inconsistent  with  the 
hypothesis  that modification of thrombin  with TNM influ- 
ences substrate binding. However, it could be argued that 
these substrates do not accurately reflect the activity of 
thrombin  toward fibrinogen (34). Therefore,  kinetic  constants 
for the release of fibrinopeptide A from bovine fibrinogen 
were obtained. The  rate of fibrinopeptide release  was obtained 
by HPLC  analysis.  The  results of this  experiment  are shown 
in  Table 11. K, values  for nitrated  thrombin  and  the  control 
preparations were essentially  identical,  whereas  there was a 
marked decrease in kcat for the  nitrated enzyme. The  kinetic 
constants  obtained for the  control  thrombin  preparation  are 
consistent  with  those  reported by other  investigators (29). 
DISCUSSION 
The initial bias of this study was that the apparently 
selective inactivation of the fibrinogen-clotting activity of 
thrombin by TNM resulted  from  the modification of a specific 
fibrinogen-binding  site  on  the  surface of thrombin.  Results 
obtained show that modification of active  site  reactivity,  not 
fibrinogen binding,  is responsible  for the  change  in  catalytic 
activity. Therefore,  the  initial  hypothesis  is  essentially  incor- 
rect. 
The  data  obtained  are quivocal in  regard  to  the  change  in 
catalytic  activity  being  due to modification of a  single,  specific 
tyrosine residue  modification  by TNM.  Results  obtained  from 
experiments  examining  the effect of TNM  concentration  on 
inactivation  rate  and  from  experiments  evaluating  the  corre- 
lation of nitrotyrosine  formation  with  the loss of fibrinogen- 
clotting  activity suggest that  the loss of biological activity  is 
the  result of the modification of a single tyrosine residue. I t  
is acknowledged that  the  data  on  the  effect of TNM concen- 
tration on the rate of inactivation are also consistent with 
two sites having essentially equal reactivity. However, our 
laboratory (35) has previously shown that reaction of N -  
butyrylimidazole with thrombin results in the modification 
on only 1 mol of tyrosine/mol of protein at maximum inacti- 
vation. 
Alternatively,  results of structural analysis of the modified 
protein indicate that modification at  both Tyr7’ and Tyra5 
with  TNM occurred concomitant with the  change in catalytic 
activity. I t  is possible that modification at  either esidue  might 
result  in loss of activity or that,  although  both  are modified, 
only one of the  sites  is responsible  for the changes  in catalytic 
activity assessed. 
The effect of solvent  conditions  on  the  rate of inactivation 
of thrombin by TNM is of interest considering other  results 
in  the  literature.  Our  laboratory (33,34) has shown that NaCl 
has a significant effect on  the  catalytic  properties of a-throm- 
bin.  However, the decreased rate  in  phosphate buffer is not 
solely a result of the  presence of sodium ions. Although the 
effect of solvent  on  the  rate of reaction was not  pursued  in 
greater  detail,  there  appears  to be a specific effect of phos- 
phate.  Berliner et al. (36) have studied  the effect of inorganic 
phosphate  and organic phosphates  on  the  interaction of 
thrombin with nonpolymerized fibrin. Inorganic phosphate 
decreased the  affinity of thrombin for  fibrin at  concentrations 
similar  to  those  used  in  this study. 
A major problem with  this  study resides in providing an 
adequate  explanation for the observation that  the modifica- 
tion of thrombin with TNM results in an enzyme with a 
decreased kcat and  unchanged K,. With  all  three  substrates 
used in  this  study,  Tos-Gly-Pro-Arg-pNA,  H-D-Phe-Pip-Arg- 
pNA,  and fibrinogen, a marked decrease was observed in kcat 
with little, if any, change in K,. As assessed by active site 
titration, the reaction of TNM with thrombin under our 
experimental  conditions does not affect  reaction with  NPGB, 
an  ester  substrate which is used as  an active site  titrant for 
thrombin (23). Thus,  the observed  decrease in kc,, is not  the 
result of total loss of active  site  integrity.  The lack of effect 
of reaction with TNM on active site reactivity of thrombin 
differs from the report of Glenn et al. (37) who reported a 
greater  than 60% decrease in reactivity  with NPGB  after  the 
modification of approximately 4 tyrosine residues  in human 
thrombin  with  TNM. 
An accurate  three-dimensional  structure for thrombin  has 
not yet been developed. Furie et al. (38) have developed a 
structure for thrombin based on homology with the  pancreatic 
serine  proteases.  The  structure developed by these investiga- 
tors is divided into two general regions: constant regions 
where there  is extensive homology to  the  pancreatic  serine 
proteases  and variable  regions  where there  is much  less struc- 
tural homology. According to  this  structure,  both Tyr7’ and 
Tyr”  are located in a variable region which is suggested to 
have an  important role in fibrinogen  binding. These residues 
are also  located in  the region of the  protein where  proteolysis 
occurs during the conversion of a-thrombin  to  P-thrombin 
(2). We have  previously  shown that  the loss of the fibrinogen- 
clotting  activity of @-thrombin  is  the  result of a Kc,, change 
and  not  the loss of a  fibrinogen-binding site (39). Cook et al. 
(40), using  a series of peptide  thioesters  as  substrates,  dem- 
onstrated  that  nitrated  human  thrombin  has a decreased kcat 
and  an increased K,,, with  all  substrates  tested.  Similar  behav- 
ior was shown by y-thrombin.  These  investigators suggested 
that  the modification of tyrosine residues  with TNM results 
in a conformational change  similar to  that  seen  in  the limited 
proteolysis of human  a-thrombin  to produce y-thrombin. 
On  the  basis of the above discussion, we suggest that  the 
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initial reaction of TNM with thrombin  results  in the disrup- 
tion of the relationship between Aspw and His43, reducing 
efficiency of concerted proton  transfer  during  the catalysis of 
the hydrolysis of specific substrates by thrombin. The impor- 
tance of concerted proton  transfer  has been suggested to be 
critical in the efficiency of catalysis by regulatory proteases 
with their specific substrates (41,42). 
More extensive nitration may result in additional changes 
in  the properties of thrombin.  Nitrated  thrombin prepared by 
our earlier procedure, having approximately 4 tyrosine resi- 
dues modified, did not  demonstrate high affinity binding to 
platelets (43). Alexander et aL (44), using nitrated human 
thrombin with a similar extent of modification, have also 
reported decreased reactivity with platelets. Other  studies (37, 
45) on the interaction of highly nitrated human thrombin 
with fibroblasts have shown decreased binding compared to 
control preparations. These  studies suggest that  there may  be 
tyrosine residues in thrombin which are critical for binding 
with macromolecular substrates,  but which are less reactive 
with TNM. 
In conclusion, the reaction of TNM with bovine a-thrombin 
results in the formation of a modified protein with decreased 
catalytic activity. The loss of activity appears to result from 
the modification of active site reactivity rather than from 
modification of a residue actually involved directly in  either 
catalysis or substrate binding. 
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